Merck Juvisync for Type 2 Diabetes receives FDA approval
Juvisync combines Januvia (sitagliptin), the glucose-lowering medication with the cholesterol-lowering medication Zocor (simvastatin). According to the company, Juvisync is said to provide blood sugar-lowering benefits of a DPP-4
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.